Genesis HealthCare (GEN) Reports In-Line Q3 EPS

Go back to Genesis HealthCare (GEN) Reports In-Line Q3 EPS

Genesis HealthCare Reports Third Quarter 2015 Results

November 5, 2015 4:12 PM EST

KENNETT SQUARE, Pa., Nov. 5, 2015 /PRNewswire/ -- 

Strong Third Quarter Performance and Growth With Pro Forma1 Adjusted: EBITDAR of $188.8 Million, up 6.3% from Prior Year Quarter EBITDA of $67.2 Million, up 13.1% from Prior Year Quarter Diluted EPS of $0.07 Recent HUD Financing Approval Advances Balance Sheet Restructuring Initiatives; Expected to Improve Annual Free Cash Flow $25 - $30 Million

Genesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United... More

Genesis HealthCare Reports Third Quarter 2015 Results

November 5, 2015 4:04 PM EST

KENNETT SQUARE, Pa., Nov. 5, 2015 /PRNewswire/ -- 

Strong Third Quarter Performance and Growth With Pro Forma1 Adjusted: EBITDAR of $188.8 Million, up 6.3% from Prior Year Quarter EBITDA of $67.2 Million, up 13.1% from Prior Year Quarter Diluted EPS of $0.07 Recent HUD Financing Approval Advances Balance Sheet Restructuring Initiatives; Expected to Improve Annual Free Cash Flow $25 - $30 Million

Genesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United... More